IVVD

Invivyd, Inc.

There isn't enough reported data to score IVVD yet.

IVVD Fundamentals

MetricStatus
Healthy
Under pressure
Weak
Unavailable

IVVD's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

IVVD PE Valuation

IVVD has no meaningful PE right now: it lost money over the past year.

IVVD Forward outlook

MetricOutlook
--
Losses steady
Growth
--
Limited
Moderate

Analysts expect IVVD's revenue to grow, with its earnings and profitability holding steady.

IVVD Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $0.57 on Nov 12.

There is not enough scenario data to assess IVVD's risk to reward.

IVVD Earnings Per Share

Q3 2023: $-1.55Q4 2023: $-1.81Q1 2024: $-1.87Q2 2024: $-1.81Q3 2024: $-1.96Q4 2024: $-1.43Q1 2025: $-1.19Q2 2025: $-0.91Q3 2025: $-0.46
Q3 2023: $-1.55Q4 2023: $-1.81Q1 2024: $-1.87Q2 2024: $-1.81Q3 2024: $-1.96Q4 2024: $-1.43Q1 2025: $-1.19Q2 2025: $-0.91Q3 2025: $-0.46
QuarterTTM EPSYoY
Q3 2025-$0.46+$1.50
Q2 2025-$0.91+$0.90
Q1 2025-$1.19+$0.68
Q4 2024-$1.43+$0.38
Q3 2024-$1.96-$0.41
Q2 2024-$1.81-$0.20
Q1 2024-$1.87-$0.25
Q4 2023-$1.81+$0.42

IVVD is still losing money, but far less than before: $0.46 per share over the past year, against $3.15 at its worst in mid-2022.

IVVD Quarterly Revenue

Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: $2MQ3 2024: $9MQ4 2024: $14MQ1 2025: $11MQ2 2025: $12MQ3 2025: $13MQ4 2025: $17MQ1 2026: $14MQ2 2026: $14M
Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: $2MQ3 2024: $9MQ4 2024: $14MQ1 2025: $11MQ2 2025: $12MQ3 2025: $13MQ4 2025: $17MQ1 2026: $14MQ2 2026: $14M
QuarterRevenueYoY
Q2 2026$14.3M+21%
Q1 2026$13.7M+22%
Q4 2025$17.2M+25%
Q3 2025$13.1M+41%
Q2 2025$11.8M+421%

IVVD's revenue has grown year over year every quarter since mid-2024: $14M last quarter, up 21% from the same quarter a year ago.

IVVD Free Cash Flow

Q3 2023: −$35MQ4 2023: −$59MQ1 2024: −$50MQ2 2024: −$42MQ3 2024: −$41MQ4 2024: −$38MQ1 2025: −$21MQ2 2025: −$13MQ3 2025: −$8MQ4 2025: −$15MQ1 2026: −$42MQ2 2026: −$44M
Q3 2023: −$35MQ4 2023: −$59MQ1 2024: −$50MQ2 2024: −$42MQ3 2024: −$41MQ4 2024: −$38MQ1 2025: −$21MQ2 2025: −$13MQ3 2025: −$8MQ4 2025: −$15MQ1 2026: −$42MQ2 2026: −$44M
QuarterFree cash flowYoY
Q2 2026-$43.5M-$30.2M
Q1 2026-$42.4M-$21.2M
Q4 2025-$15.5M+$22.2M
Q3 2025-$8.3M+$32.8M
Q2 2025-$13.3M+$28.3M
Q1 2025-$21.3M+$29.1M
Q4 2024-$37.6M+$21.6M
Q3 2024-$41.1M-$5.7M

IVVD has burned cash in almost every quarter: −$110M over the past year, against −$113M the year before.

IVVD Total Shares

Q3 2023: 110MQ4 2023: 110MQ1 2024: 116MQ2 2024: 119MQ3 2024: 119MQ4 2024: 119MQ1 2025: 120MQ2 2025: 120MQ3 2025: 170MQ1 2026: 310MQ2 2026: 320M
Q3 2023: 110MQ4 2023: 110MQ1 2024: 116MQ2 2024: 119MQ3 2024: 119MQ4 2024: 119MQ1 2025: 120MQ2 2025: 120MQ3 2025: 170MQ1 2026: 310MQ2 2026: 320M
PeriodChange %Net change
Quarterly+3.5%+10.8M shares
1 year+167%+201M shares
3 years+195%+212M shares
5 years+407%+257M shares

IVVD has 320M diluted shares, up 167% from a year ago.

IVVD Net Leverage

IVVD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

IVVD Weekly Momentum

MetricValueStatus
RSI37.5Neutral
Stochastic7.0Oversold

IVVD's weekly RSI is 38 (neutral) and its Stochastic is 7 (oversold).

IVVD PE vs Healthcare Sector

IVVD has no meaningful PE right now: it lost money over the past year.

IVVD Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$0.6816% below
20 week MA$0.7423% below
50 week MA$1.2956% below
100 week MA$1.1651% below
200 week MA$1.5263% below

IVVD is in a downtrend: it's below all five of its weekly moving averages, and 63% below its 200-week average.

IVVD Yearly ROI

YearStart priceEnd priceROI
2021$20.9$8.66-59%
2022$8.66$1.70-80%
2023$1.70$3.94+132%
2024$3.94$0.51-87%
2025$0.51$2.69+427%
2026 YTD$2.69$0.57-79%

IVVD's yearly returns have swung widely, from +427% in 2025 to −87% in 2024. It's down 79% so far in 2026.

Give your agent the market.

Get API key